Healthcare Contract Manufacturing

Healthcare Contract Manufacturing Market by Manufacturing Type (Accessories Manufacturing, Assembly Manufacturing, Component Manufacturing), End-Users (Medical Device Companies, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2024-2030

360iResearch Analyst
Want to know more about the healthcare contract manufacturing market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[195 Pages Report] The Healthcare Contract Manufacturing Market size was estimated at USD 186.00 billion in 2023 and expected to reach USD 201.68 billion in 2024, at a CAGR 8.49% to reach USD 329.22 billion by 2030.

Healthcare Contract Manufacturing Market
To learn more about this report, request a free PDF copy
The healthcare contract manufacturing market comprises firms that offer a range of services, from drug formulation and development to medical devices and components manufacturing for other healthcare organizations. This market enables healthcare companies to outsource certain aspects of their operations, which can lead to lowered costs, increased flexibility, and access to advanced manufacturing technologies and expertise. The major factors propelling the growth of the healthcare contract manufacturing market include the increasing demand for generic medicines, the rising prevalence of chronic diseases, the need for advanced medical devices, and the surge in the introduction of new therapeutic methodologies. However, stringent regulatory compliances, varying international standards, and the pressure of maintaining high-quality processes while reducing costs are the major restraining factors hindering market growth. The opportunities within the healthcare contract manufacturing market are driven by technological advancements such as 3D printing in device manufacturing, personalized medicine, and the growing importance of regulatory compliance. Additionally, sustained investments in R&D for developing innovative biologics and medical devices and adapting to the evolving digital healthcare landscape could further enhance market competitiveness.
Healthcare Contract Manufacturing Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Manufacturing Type: Advancements in the manufacturing processes offer customized solutions for diverse client requirements through contract manufacturing

Healthcare contract manufacturing encompasses various production processes, including accessories, assembly, components, devices, and pharmaceutical manufacturing. These processes support end-users, including hospitals, clinics, diagnostic centers, and home care settings, by providing supplementary items for medical devices and equipment. Assembly manufacturing involves assembling components or subassemblies into a final product used in medical treatments and procedures. Component manufacturing focuses on producing specific parts for medical devices or equipment, such as sensors, motors, enclosures, or casings. Device manufacturers develop and produce complete medical devices or equipment essential for patient care while adhering to regulatory compliance standards. Pharmaceutical manufacturing entails the production of medications such as drugs, vaccines, and biopharmaceuticals while maintaining strict adherence to Good Manufacturing Practices (GMP) guidelines. As technological advancements propel the healthcare sector's rapid growth trajectory alongside increasing global demand for quality products and services, manufacturers play a critical role in delivering innovative solutions tailored to diverse client requirements.

End-User: Contract manufacturers expanded penetration to develop highly complex biological products

The healthcare contract manufacturing market is divided into three primary end-user segments comprising biopharmaceuticals, medical devices, and pharmaceuticals. Each sector has distinct requirements based on product demands and regulatory environments. Major contract manufacturers focus on developing complex biological products, including recombinant proteins, monoclonal antibodies, vaccines, and gene therapies. Additionally, medical device producers and service providers assist with designing, prototyping, and mass-producing various types of Class I-III devices. These businesses require expertise in microfabrication techniques and adherence to ISO 13485 certifications for quality management systems specific to medical devices. Pharmaceutical contract manufacturers provide services such as active pharmaceutical ingredient synthesis, formulation development, clinical trial material supply, analytical testing, and commercial-scale production of small molecule drugs under strict cGMP conditions. Significant players demand specialized skills from contract manufacturers while adhering to stringent regulations. The biopharmaceutical sector prioritizes advanced bioprocessing technologies, medical device manufacturers emphasize microfabrication techniques, and pharmaceutical companies necessitate small molecule drug production under cGMP conditions. Continuous growth in these sectors demonstrates a strong demand for healthcare contract manufacturing services tailored to each subcategory's unique needs.

Regional Insights

The Americas has significant market growth due to highly developed healthcare infrastructure and stringent regulatory requirements in the region. The increased focus on bringing down healthcare costs has led to a surge in outsourcing to contract manufacturing organizations (CMOs), particularly for pharmaceuticals and medical devices in the North American region. European Countries are at the forefront of healthcare research and development, bolstered by strong government support and collaborations between academia and industry. The growing investments from the public and private sectors in areas such as personalized medicine, genomics, digital health solutions, and advanced therapies further drive the growth of healthcare contract manufacturing in the EMEA region. China, Japan, and India are witnessing significant growth in healthcare contract manufacturing due to rising domestic demand, cost advantages, and technological advances. The Asia Pacific (APAC) region has emerged as a medical device and pharmaceutical manufacturing hub, leading to strategic business expansions by contract manufacturing organizations in the APAC market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Healthcare Contract Manufacturing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Healthcare Contract Manufacturing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Biomerics Announces Merger with Precision Concepts Medical

    Biomerics LLC, a major player in vertically integrated contract manufacturing in the interventional medical device sector, has announced its strategic merger with Precision Concepts Medical. This significant transaction encompasses the acquisition of Precision Concepts International's (PCI) medical business and Precision Concepts Group (PCG), headquartered in Winston-Salem, North Carolina. This merger between Biomerics LLC and Precision Concepts Medical strengthened their presence in the healthcare contract manufacturing landscape. [Published On: 2023-05-17]

  • PCI Pharma Unveils Plans for USD 50 Millions Expansion At Illinois Injectables Site

    PCI Pharma Services, a biopharmaceutical contract manufacturing organization, recently announced its plans for a significant USD 50 million expansion at its Rockford, Illinois-based sterile injectables facility. The project is expected to involve the construction of a state-of-the-art 200,000-square-foot site that aims to substantially enhance the plant's production capacity for injectable drug-device combination products. The ambitious expansion initiative underscores PCI Pharma Services' commitment to addressing the growing demand for high-quality sterile injectable solutions while maintaining its position as a trusted and reliable partner in the biopharmaceutical sector. [Published On: 2023-03-16]

  • Medisurge and Signal Medical Announce Strategic Partnership

    Medisurge, a healthcare contract manufacturing player, has announced its exclusive partnership with Signal Medical Corporation. Signal Medical has built a solid reputation for manufacturing high-quality knee and hip implants and providing advanced instrument systems to orthopedic surgeons. This strategic partnership between Medisurge and Signal Medical facilitates growth expansion for both companies in the competitive orthopedic market. By combining their expertise and resources, the partnership aims to establish an even stronger presence and provide enhanced services to clients within the industry. [Published On: 2023-01-25]

Key Company Profiles

The report delves into recent significant developments in the Healthcare Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Group, Almac Group, Baxter International, Inc., Biozoc Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Curia Global, Inc., Evonik Industries AG, Famar Group, Jubilant Biosys Limited, Lonza Group Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Pidolma Healthcare Private Limited, Recipharm AB, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Healthcare Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Manufacturing Type
    • Accessories Manufacturing
    • Assembly Manufacturing
    • Component Manufacturing
    • Device Manufacturing
    • Pharmaceutical Manufacturing
      • Advanced Drug Delivery Formulations
      • API/Bulk Drugs
      • Finished Dose Formulations
      • Packaging
  • End-Users
    • Medical Device Companies
    • Pharmaceutical & Biopharmaceutical Companies

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Healthcare Contract Manufacturing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Healthcare Contract Manufacturing Market?
  3. What are the technology trends and regulatory frameworks in the Healthcare Contract Manufacturing Market?
  4. What is the market share of the leading vendors in the Healthcare Contract Manufacturing Market?
  5. Which modes and strategic moves are suitable for entering the Healthcare Contract Manufacturing Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Healthcare Contract Manufacturing Market, by Manufacturing Type
  7. Healthcare Contract Manufacturing Market, by End-Users
  8. Americas Healthcare Contract Manufacturing Market
  9. Asia-Pacific Healthcare Contract Manufacturing Market
  10. Europe, Middle East & Africa Healthcare Contract Manufacturing Market
  11. Competitive Landscape
  12. Competitive Portfolio
  13. List of Figures [Total: 20]
  14. List of Tables [Total: 290]
  15. List of Companies Mentioned [Total: 17]
Healthcare Contract Manufacturing: A One-Stop-Shop Solution for the Increasing Market Demand
September 29, 2023
Healthcare Contract Manufacturing: A One-Stop-Shop Solution for the Increasing Market Demand
Contract manufacturing organizations (CMOs) have been instrumental in the pharmaceutical industry for decades. As healthcare and pharmaceutical companies face increasing demands for innovative therapies, efficiency, and cost-effectiveness, they turn to CMOs for strategic partnerships. CMOs offer expertise in manufacturing, packaging, labeling, and logistics of pharmaceuticals and medical devices. One-stop-shop contract development and manufacturing organizations (CDMOs) are gaining popularity in the healthcare industry. This blog post delves into the increasing demand for healthcare contract manufacturing and explores how CDMOs address these needs.

The demand for CDMO services is driven by many factors, the primary one being the increasing demand for innovative treatments for unmet medical needs. With patent expirations, generic competition, and rising R&D costs, pharmaceutical and medical device companies outsource the manufacturing of their products to CDMOs to minimize overall costs. CDMOs provide end-to-end services that range from drug development and clinical trials to commercial production. One-stop-shop CDMOs ensure seamless collaboration between the clients and the CDMO under one roof, thus streamlining the manufacturing process.

Another critical driver for one-stop-shop CDMOs is the global rise in chronic diseases, which has put pressure on healthcare systems worldwide. The healthcare industry is shifting away from the traditional fee-for-service care model to value-based care that emphasizes patient outcomes and cost-effectiveness. One-stop-shop CDMOs help healthcare providers customize patient care by developing and manufacturing personalized therapies that meet the unique needs of patients.

The increasing demand for CDMOs is also driven by technological developments, such as artificial intelligence (AI) and big data analytics, that offer insights into disease pathology and personalized medicine. One-stop-shop CDMOs invest in technology to increase efficiency, lower costs, and accelerate the drug development process. For instance, they use predictive modeling to optimize drug formulations, reduce clinical trial timelines, and enhance the quality of the final product.

Furthermore, the COVID-19 pandemic has highlighted the requirement for agile manufacturing systems that can respond to the changing market needs quickly. One-stop-shop CDMOs with a global presence have been instrumental in developing COVID-19 vaccines, therapeutics, and diagnostics. They work closely with governments and regulatory agencies to ensure timely product development and delivery. The pandemic surged the adoption of digital technologies and remote work models that one-stop-shop CDMOs have embraced to provide uninterrupted services to clients.

Healthcare contract manufacturing is a growing sector that offers one-stop-shop solutions for industry players. One-stop-shop CDMOs provide customers with streamlined services and end-to-end product development and manufacturing solutions. Increasing demand for efficient and personalized healthcare, rising chronic disease prevalence, advances in technology, and COVID-19 have all contributed to the growth of this sector. One-stop-shop CDMOs are well-positioned to deliver innovative therapies that meet patient needs, reduce costs, and accelerate drug development timelines. Partnering with a trusted CDMO can help healthcare and pharmaceutical companies stay competitive and make a meaningful impact on global health.

Frequently Asked Questions
  1. How big is the Healthcare Contract Manufacturing Market?
    Ans. The Global Healthcare Contract Manufacturing Market size was estimated at USD 186.00 billion in 2023 and expected to reach USD 201.68 billion in 2024.
  2. What is the Healthcare Contract Manufacturing Market growth?
    Ans. The Global Healthcare Contract Manufacturing Market to grow USD 329.22 billion by 2030, at a CAGR of 8.49%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.